Navigation Links
WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
Date:2/18/2010

SHANGHAI, Feb. 18 /PRNewswire-Asia-FirstCall/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the fourth quarter of 2009 after the New York Stock Exchange closes on Monday, March 8, 2010 (which will be Tuesday morning, March 9, 2010 Shanghai time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The earnings release will be available on the investor relations section of its website at http://www.wuxiapptec.com .

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 9:00 pm (Beijing/Shanghai/Hong Kong) on Tuesday, March 9, 2010, to discuss the fourth-quarter 2009 financial results and recent business activities. The conference call may be accessed by calling:

    
    
    United States:          1-866-519-4004
    China (Landline):       800-819-0121
    China (Mobile):         400-620-8038
    Hong Kong:              800-930-346
    United Kingdom:         0-808-234-6646
    International:          +65-6733-0019
    Conference ID:          57898803

A telephone replay will be available two hours after the call's completion at:

    
    
    United States:            1-866-214-5335
    China North:              10-800-714-0386
    China South:              10-800-140-0386
    Hong Kong:                800-901-596
    United Kingdom:           0-800-731-7846
    International:            +61-2-8235-5000
    Conference ID:            57898803

A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com .

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.

    
    
    For more information, please contact:
    
    Ronald Aldridge
    Director of Investor Relations
    WuXi PharmaTech (Cayman) Inc.
    Tel:   +1-201-585-2048
    Email: Ron_Aldridge@wuxiapptec.com

Web: http://www.wuxiapptec.com  

SOURCE WuXi PharmaTech (Cayman) Inc.

RELATED LINKS
http://www.wuxiapptec.com

'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
2. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
3. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
4. Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter and Full Year 2009 Results
5. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
6. Roper Industries Schedules Fourth Quarter 2009 Financial Results Conference Call
7. Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call
8. Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern
9. VirtualScopics Schedules Third Quarter 2009 Earnings Announcement
10. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
11. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... HEIGHTS, Utah , Feb. 8, 2016 /PRNewswire/ ... and distributor of advanced-technology medical devices and rehabilitation ... related markets, congratulates the Denver Broncos, football team ... Kelvyn H. Cullimore Jr. , Chairman and Chief ... of excellence and we look forward to enhancing ...
(Date:2/8/2016)... 2016 --> ... Allied Market Research titled, "World Synthetic Biology ... estimates the world synthetic biology market to be ... technology segment would continue to lead the market ... collectively, held around half of the market share ...
(Date:2/5/2016)... OAKS, Calif. , Feb. 5, 2016 Amgen ... 5 th Annual Global Healthcare Conference at 9:15 a.m. ... York City . David W. Meline , executive ... at the conference. Live audio of the presentation can be ... , under Investors. A replay of the webcast will also ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California and its affiliated ... , Gary D. Radine, who recently retired as president and CEO of Delta Dental ... 2015 CEO of the Year , helped lead the effort to raise funds for ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... of organizations. DocuSyst provides a cloud hosted environment for FileHold software that ... integration with various 3rd party applications using the FileHold web services API. DocuSyst ...
(Date:2/8/2016)... ... 08, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to a ... derived from a cluster of melanin when exposed to sunlight. Although most moles are ... lifetime of embarrassment. Historically, mole removal has involved a painful, often expensive ...
(Date:2/8/2016)... ... , ... According to research by the National Association of ... be certified or obtain continuing education. To increase patient awareness of the lack ... campaign to inform dentists and patients about the possible lack of skills and ...
(Date:2/7/2016)... , ... February 07, 2016 , ... ... Facial Plastics, has added Kybella® to his medical and surgical expertise. Technically known ... approved FDA injectable medication used as a non-surgical alternative for reduction of fat ...
Breaking Medicine News(10 mins):